2014
DOI: 10.2332/allergolint.13-oa-0683
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Bifidobacterial Supplementation to Pregnant Women and Infants in the Prevention of Allergy Development in Infants and on Fecal Microbiota

Abstract: These data suggest that the prenatal and postnatal supplementation of bifidobacteria is effective in primary preventing allergic diseases. Some limited changes in the composition of fecal microbiota by the bifidobacterial supplementation were observed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
95
0
4

Year Published

2015
2015
2024
2024

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 142 publications
(100 citation statements)
references
References 42 publications
1
95
0
4
Order By: Relevance
“…This bacterium produces high levels of SCFAs and promotes epithelial integrity (Fukuda et al, 2011). Bifidobacterium alleviates food allergy in mice (Kim et al, 2016) and its administration to pregnant women significantly reduced allergy in offspring, and this correlated with changes in gut microbiota composition (Enomoto et al, 2014), possibly through SCFA elevation. Oral immunotherapy with the probiotic Lactobacillus Rhamnosus, a high-SCFA producer, led to peanut unresponsiveness in 82% of allergic children (Tang et al, 2015).…”
Section: Discussionmentioning
confidence: 98%
“…This bacterium produces high levels of SCFAs and promotes epithelial integrity (Fukuda et al, 2011). Bifidobacterium alleviates food allergy in mice (Kim et al, 2016) and its administration to pregnant women significantly reduced allergy in offspring, and this correlated with changes in gut microbiota composition (Enomoto et al, 2014), possibly through SCFA elevation. Oral immunotherapy with the probiotic Lactobacillus Rhamnosus, a high-SCFA producer, led to peanut unresponsiveness in 82% of allergic children (Tang et al, 2015).…”
Section: Discussionmentioning
confidence: 98%
“…8486 In an open trial of potential treatment for reduced gut bacterial diversity in AD, mothers were supplemented with Bifidobacterium starting at 1 month before delivery followed by Bifidobacterium supplementation to the infant until 6 months of age. 87 Compared to unsupplemented controls, the supplemented infants were found to have reduced risk of developing AD during the first 18 months of life, and pyrosequencing analyses showed differences in gut microbiota in those who developed AD. 87 …”
Section: Microbiomementioning
confidence: 94%
“…87 Compared to unsupplemented controls, the supplemented infants were found to have reduced risk of developing AD during the first 18 months of life, and pyrosequencing analyses showed differences in gut microbiota in those who developed AD. 87 …”
Section: Microbiomementioning
confidence: 94%
“…Это позволило увеличить кишечную популяцию бактероидов, лактоба-цилл, бифидобактерий и энтерококков, тогда как количество Clostridium coccoides уменьши-лось. Лечение также восстановило нормальное соотношение Th1/Th2 [7,98].…”
Section: изменения микробиоты при заболеваниях кожиunclassified